Breaking News Instant updates and real-time market news.

IRWD

Ironwood

$15.69

-0.23 (-1.44%)

08:16
10/07/16
10/07
08:16
10/07/16
08:16

Ironwood head of clinical research dies in bike crash, Boston Herald reports

Dr. Bernard "Joe" Lavins Jr., the head of clinical research at Ironwood Pharmaceuticals, was killed Wednesday morning when the bike he was riding collided with an 18-wheel tractor-trailer, reported the Boston Herald. Lisa Adler, a company spokeswoman, said Lavins Jr. was a "superb scientist and a data hound, never afraid to ask the hard questions, always pushing us to be our best, embodying the highest of ethical standards and never losing sight of why we all come into the office every day: to help patients. He raised the bar for all of us and embodied the smart, compassionate company we strive to be...For this quiet and caring individual, it's hard to overstate the impact he had on the world. He left us much too soon." Reference Link

  • 06

    Nov

IRWD Ironwood
$15.69

-0.23 (-1.44%)

04/06/16
04/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CRH (CRH) upgraded to Overweight at JPMorgan by analyst Elodie Rall, who views the valuation as attractive and sees limited risk to estimates. 2. Ironwood (IRWD) upgraded to Outperform at Cowen citing the company's pipeline and ex-U.S. royalties as well as U.S. co-marketing agreements leaving room for growth. 3. Owens-Illinois (OI) upgraded to Buy at Citi with analyst Anthony Pettinari citing valuation and a low bar set by management for 2016. 4. Pennsylvania REIT (PEI) upgraded to Outperform at Boenning & Scattergood by analyst Floris van Dijkum, who believes Pennsylvania REIT's discounted valuation is unwarranted given significant acceleration in 2018 NOI growth. van Dijkum expects the company to continue to reduce leverage by selling other non-core assets and make development progress on the Fashion Outlets of Philadelphia. 5. Cisco (CSCO) upgraded to Neutral at JPMorgan with analyst Rod Hall saying the company's 3.8% dividend yield is "compelling in the midst of current market volatility." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/26/16
JPMS
04/26/16
NO CHANGE
JPMS
Ironwood Linzess safety concerns overblown, says JPMorgan
04/26/16
COWN
04/26/16
NO CHANGE
COWN
Outperform
Ironwood short report does not discuss any new information, says Cowen
Cowen analyst Boris Peaker,commented on the short report on Ironwood (IRWD) issued by Phase Five Research and said it doesn't appear to discuss any new data. Peaker said the analysis ignores the co-morbidities of patients that are on Linzess, which has been in 2M patients, many with significant other illnesses and on multiple other background therapies. Additionally, the report overlooked the acquisition of Zurampic today from AstraZeneca (AZN) that was favorably structured with a $100M upfront payment to Ironwood, the analyst said. Peaker said feedback on Linzess from consultants at Cowen's Healthcare Conference was positive and reiterates his Outperform rating.
04/27/16
UBSW
04/27/16
NO CHANGE
Target $8
UBSW
Sell
Ironwood had no new safety concerns with Linzess, says UBS
UBS said the FDA had no new safety concerns and there were no regulatory actions required for Ironwood's Linzess drug. The firm expects the noise from yesterday's short report, which suggested the FDA had issues with Linzess, to subside as the safety concerns pointed to were not justified. UBS acknowledges they have not given much credit for the company's pipeline, but they prefer to stay on the sidelines and take a "wait and see" attitude. UBS maintained its Sell rating and $8 price target on Ironwood shares.

TODAY'S FREE FLY STORIES

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$121.43

0.45 (0.37%)

06:49
09/26/17
09/26
06:49
09/26/17
06:49
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$126.99

0.79 (0.63%)

06:49
09/26/17
09/26
06:49
09/26/17
06:49
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$16.21

0.16 (1.00%)

06:48
09/26/17
09/26
06:48
09/26/17
06:48
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INT

World Fuel Services

$36.74

0.12 (0.33%)

06:48
09/26/17
09/26
06:48
09/26/17
06:48
Downgrade
World Fuel Services rating change  »

World Fuel Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOXO

XO Group

$18.95

-0.09 (-0.47%)

06:48
09/26/17
09/26
06:48
09/26/17
06:48
Conference/Events
XO Group to host analyst breakfast meeting »

Analyst Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

USLV

VelocityShares 3x Long Silver ETN

$12.55

0.4 (3.29%)

06:48
09/26/17
09/26
06:48
09/26/17
06:48
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$79.82

0.43 (0.54%)

06:47
09/26/17
09/26
06:47
09/26/17
06:47
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$331.40

1.46 (0.44%)

06:47
09/26/17
09/26
06:47
09/26/17
06:47
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$5.01

-0.06 (-1.18%)

06:47
09/26/17
09/26
06:47
09/26/17
06:47
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$24.46

-0.31 (-1.25%)

06:46
09/26/17
09/26
06:46
09/26/17
06:46
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$31.86

-0.33 (-1.03%)

06:46
09/26/17
09/26
06:46
09/26/17
06:46
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$71.94

0.22 (0.31%)

06:46
09/26/17
09/26
06:46
09/26/17
06:46
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCC

Calgon Carbon

06:45
09/26/17
09/26
06:45
09/26/17
06:45
Downgrade
Calgon Carbon rating change  »

Calgon Carbon downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$44.61

-0.77 (-1.70%)

06:45
09/26/17
09/26
06:45
09/26/17
06:45
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$41.27

-0.41 (-0.98%)

06:45
09/26/17
09/26
06:45
09/26/17
06:45
Periodicals
BHP expects electric car shift to first impact copper, Reuters reports »

BHP sees 2017 as the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$22.45

-2.09 (-8.52%)

06:45
09/26/17
09/26
06:45
09/26/17
06:45
Upgrade
Dova Pharmaceuticals rating change  »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

EWW

iShares MSCI Mexico

$55.59

-0.4 (-0.71%)

06:44
09/26/17
09/26
06:44
09/26/17
06:44
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HABT

Habit Restaurants

06:44
09/26/17
09/26
06:44
09/26/17
06:44
Downgrade
Habit Restaurants rating change  »

Habit Restaurants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$24.07

0.14 (0.59%)

06:44
09/26/17
09/26
06:44
09/26/17
06:44
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$33.61

0.34 (1.02%)

06:44
09/26/17
09/26
06:44
09/26/17
06:44
Downgrade
Shake Shack rating change  »

Shake Shack downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAKE

Cheesecake Factory

$41.60

0.08 (0.19%)

06:43
09/26/17
09/26
06:43
09/26/17
06:43
Downgrade
Cheesecake Factory rating change  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$22.41

-0.1001 (-0.44%)

06:43
09/26/17
09/26
06:43
09/26/17
06:43
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$147.07

-0.33 (-0.22%)

06:42
09/26/17
09/26
06:42
09/26/17
06:42
Recommendations
Illinois Tool Works analyst commentary  »

Citi says 'too soon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LCI

Lannett

$17.10

-0.3 (-1.72%)

06:41
09/26/17
09/26
06:41
09/26/17
06:41
Hot Stocks
Lannett announces dismissal of class action lawsuit »

Lannett Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLR

Digital Realty

$114.22

-0.29 (-0.25%)

06:36
09/26/17
09/26
06:36
09/26/17
06:36
Downgrade
Digital Realty rating change  »

Digital Realty resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.